Administration of dexamethasone to neonatal rats induces hypomyelination and changes in the morphology of oligodendrocyte precursors

Comparative Medicine

Volumn 63, Issue 1, 2013, Pages 48-54

  Kim, Jong Wan ^a,b   Kim, Young J ^a   Chang, Young P ^a  

^a Dankook University   (South Korea)

^b BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CORPUS CALLOSUM; CYTOPLASM; FEMALE; HEMISPHERE; IMMUNOFLUORESCENCE; NERVE CELL DEGENERATION; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOTTING, WESTERN; DEXAMETHASONE; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; MYELIN BASIC PROTEIN; MYELIN SHEATH; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS; STATISTICS, NONPARAMETRIC;

EID: 84875016632     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Almazan G, Honegger P, Du Pasquier P, Matthieu JM. 1986. Dexamethasone stimulates the biochemical differentiation of fetal forebrain cells in reaggregating cultures. Dev Neurosci 8:14-23.
2. Antonow-Schlorke I, Helgert A, Gey C, Coksaygan T, Schubert H, Nathaniels PW, Witte OW, Schwab M. 2009. Adverse effects of antenatal glucocorticoids on cerebral myelination in sheep. Obstet Gynecol 113:142-151.
3. Back SA. 2006. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 12:129-140.
4. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241-6253.
5. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22:455-463.
6. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. 2001. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21:1302-1312.
7. Back SA, Riddle A, McClure MM. 2007. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 38:724-730.
8. Committee on Fetus and Newborn. 2002. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109:330-338.
9. Craig A, Ling Luo N, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA. 2003. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231-240.
10. Crowley PA. 1995. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 173:322-335.
11. Distelhorst CW. 2002. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 9:6-19.
12. Fern R, Moller T. 2000. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate-release feedback loop. J Neurosci 20:34-42.
13. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. 1999. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180:114-121.
14. Gu C, Casaccia-Bonnefil P, Srinivasan A, Chao MV. 1999. Oligodendrocyte apoptosis mediated by caspase activation. J Neurosci 19:3043-3049.
15. Gumbinas M, Oda M, Huttenlocher P. 1973. The effects of corticosteroids on myelination of the developing rat brain. Biol Neonate 22:355-366.
16. Halliday HL, Ehrenkranz RA, Doyle LW. 2009. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 21:CD001145.
17. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. 2001. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci 19:415-425.
18. Jones RA. 2005. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics 116:370-378.
19. Kanagawa T, Tomimatsu T, Hayashi S, Shioji M, Fukuda H, Shimoya K, Murata Y. 2006. The effects of repeated corticosteroid administration on the neurogenesis in the neonatal rat. Am J Obstet Gynecol 194:231-238.
20. Melcangi RC, Magnaghi V, Cavarretta I, Riva MA, Martini L. 1997. Corticosteroid effects on gene expression of myelin basic protein in oligodendrocytes and of glial fibrillary acidic protein in type 1 astrocytes. J Neuroendocrinol 9:729-733.
21. Neuberger TJ, Kalimi O, Regelson W, Kalimi M, De Vries GH. 1994. Glucocorticoids enhance the potency of Schwann cell mitogens. J Neurosci Res 38:300-313.
22. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
23. Powell K, Kerkering KW, Barker G, Rozycki HJ. 2006. Dexamethasone dosing, mechanical ventilation, and the risk of cerebral palsy. J Matern Fetal Neonatal Med 19:43-48.
24. Raschke C, Schmidt S, Schwab M, Jirikowski G. 2008. Effects of betamethasone treatment on central myelination in fetal sheep: an electron-microscopical study. Anat Histol Embryol 37:95-100.
25. Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De Nicola AF, Baulieu EE. 2000. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol 29:307-326.
26. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E. 2000. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 83:F177-F181.
27. Skoff RP, Ghandour MS, Knapp PE. 1994. Postmitotic oligodendrocytes generated during postnatal cerebral development are derived from proliferation of immature oligodendrocytes. Glia 12:12-23.
28. Tan CK, Yan J, Ananth C, Kaur C. 2002. Dexamethasone induces dendritic alteration but not apoptosis in the neurons of the hippocampus in postnatal rats. Neurosci Lett 326:206-210.
29. Trousson A, Makoukji J, Petit PX, Bernard S, Slomianny C, Schumacher M, Massaad C. 2009. Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death. PLoS ONE 4:e8080.
30. Tsuneishi S, Takada S, Motoike T, Ohashi T, Sano K, Nakamura H. 1991. Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain. Brain Res Dev Brain Res 61:117-123.
31. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562.
32. Zhu W, Wiggins RC, Konat GW. 1994. Glucocorticoid-induced upregulation of proteolipid protein and myelin-associated glycoprotein genes in C6 cells. J Neurosci Res 37:208-212.